Each year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in 1–2% of patients and is the most severe complication of tuberculosis, arising…
Taiwan: Analysis of national data from Taiwan shows that hydroxychloroquine (HCQ), despite known long-term risks such as retinopathy, remains a cornerstone of lupus treatment. In patients with systemic lupus erythematosus…
A major pooled analysis published in JAMA has shown that sodium-glucose cotransporter 2 (SGLT2) inhibitors deliver consistent kidney and cardiovascular benefits across different patient groups—irrespective of diabetes status or baseline…
Egypt: Women with irregular menstrual cycles may face significantly higher risks of cardiovascular and metabolic disorders, a recent meta-analysis published in the European Journal of Obstetrics & Gynecology and Reproductive…
Researchers have found in a new study that an RCT showed moderate to large improvements in all OHIP-14 domains after root canal treatment (RCT). Before treatment, factors such as female…
Turkey: A pilot study published in BMC Ophthalmology suggests that a gamified, app-based multimodal visual therapy may offer meaningful benefits for children with anisometropic amblyopia that extend beyond improvements in…
And other biotech news brought to you by The Readout
French Guiana: A rare but clinically important adverse reaction linked to ethambutol has been highlighted in a new case report published in the American Journal of Case Reports, drawing attention…
Clascoterone 5% topical solution, an anti-androgen that targets the hair follicle androgen receptor without measurable systemic absorption, demonstrated significant hair regrowth in male pattern hair loss. Topline 6-month data showed…
Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per month for self-paying patients